Shameel Shafqat, Research Scholar at Mayo Clinic, posted on LinkedIn:
“Grateful to have attended ASCO2025 and presented our ongoing work on immunotherapy in recurrent gliomas under my mentor at Mayo Clinic.
Was privileged to meet our distinguished and accomplished alumni from Aga Khan University, and the cherry on top: a complimentary ASCO headshot for future ERAS!”
Read OncoDaily’s Special Articles about ASCO 2025:
Highlights from ASCO 2025 Day 1
Highlights from ASCO 2025 Day 2